COCP•benzinga•
Cocrystal Pharma's Recent Virology Study Shows Broad-Spectrum Influenza PB2 Inhibitor CC-42344 Exhibits Strong Antiviral Activity Against Highly Pathogenic H5N1 Avian Influenza A Strain
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 29, 2025 by benzinga